Methyl 3-(2-(((4-cyanophenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate

Catalog No. :
ACCJKE323
CAS No. :
211916-39-1
Molecular Formula :
C26H24N6O3
Molecular Weight :
468.52

IUPAC Name:methyl 3-(2-(((4-cyanophenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate

Methyl 3-(2-(((4-cyanophenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 3-(2-(((4-cyanophenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate
IUPAC Namemethyl 3-(2-(((4-cyanophenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate
MDL No.MFCD23101292
Molecular FormulaC26H24N6O3
Molecular Weight468.52
SMILESN#CC1=CC=C(C=C1)NCC2=NC=3C=C(C=CC3N2C)C(=O)N(C4=NC=CC=C4)CCC(=O)OC
InChI KeyNHLNCKBZUVTVHK-UHFFFAOYSA-N
SynonymDabigatran Impurity 10/Dabigatran cyano methyl ester;β-Alanine, N-[[2-[[(4-cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, methyl ester
CAS No.211916-39-1

Synthetic Route by SureRoute

1. ACCJKE323 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAIOY691 route compound structure diagram
    ACAIOY691873-74-5 In Stock
  4. Then
  5. ACCJKE323 route product structure diagram
    ACCJKE323211916-39-1
Inquiry

2. ACCJKE323 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAIOY691 route compound structure diagram
    ACAIOY691873-74-5 In Stock
  4. Then
  5. ACCJKE323 route product structure diagram
    ACCJKE323211916-39-1
Inquiry

Comments (0)